Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Gemini Genomics plc (NasdaqNM:GMNI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider
Recent Events
Aug 14Earnings Announcement
Location
162 Science Park, Milton Road
Cambridge CB4 0GH, UK
Phone: (781) 449-4328
Email: tony.ratcliffe@gemini-genomics.com
Employees (last reported count): 126
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 49%
·Institutional: 7% (14% of float)
(24 institutions)
·Net Inst. Buying: 510.0K shares (+18.51%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Gemini Genomics PLC is a clinical genomics company that uses clinical and medical information as a starting point to identify relationships between genes, human health and disease. The Company expects that its discoveries will provide it with licensable products that pharmaceutical and diagnostic companies will use in drug discovery and/or gene-based diagnostic applications. The Company already has comprehensive and diverse clinical and genetic resources collected by its clinical collaborators and its Canadian subsidiary, Newfound Genomics, from human volunteers, databases and other biological information management and analysis (bioinformatic) systems, as well as the additional resources provided by its technology collaborators. These include Celera Genomics (a division of Applera Corporation), Qiagen Genomics, Large Scale Proteomics, CuraGen, Sequenom, Rosetta Inpharmatics and Genmab.
More from Market Guide: Expanded Business Description

Financial Summary
Gemini Genomics plc is a clinical genomics company that identifies relationships between human genes and human health and disease, hoping to develop products that can be licensed to pharmaceutical, diagnostic, genomics and biotechnology companies. For the three months ended 6/30/01, the Company reported no revenue. Net loss increased 44% to $7.2 million. Higher loss reflects increased marketing costs and $2.8 million in costs related to the proposed merger with Sequenom.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
Michael Fitzgerald, 41Chairman
Paul Kelly, M.D., 40Pres, CEO, Director
Tony Ratcliffe, 36CFO
M.C. SullivanExec. VP of Corp. Communications and Bioethics
Steven Butcher, Ph.D.VP, Scientific Operations
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GMNIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$2.781
Recent Price$3.43 
52-Week High
on 6-Sep-2000
$19.375
Daily Volume (3-month avg)63.2K
Daily Volume (10-day avg)18.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-80.6%
52-Week Change
relative to S&P500
-73.9%
Share-Related Items
Market Capitalization$111.0M
Shares Outstanding32.4M
Float16.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.28 
Earnings (ttm)-$0.48 
Earnings (mrq)-$0.22 
Sales (ttm)$0.05 
Cash (mrq)$2.13 
Valuation Ratios
Price/Book (mrq)1.51 
Price/EarningsN/A 
Price/Sales (ttm)69.08 
Income Statements
Sales (ttm)$1.58M
EBITDA (ttm)-$24.9M
Income available to common (ttm)-$15.4M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-19.96%
Return on Equity (ttm)-22.75%
Financial Strength
Current Ratio (mrq)9.81 
Debt/Equity (mrq)0.04 
Total Cash (mrq)$69.1M
Short Interest
As of 8-Aug-2001
Shares Short3,000 
Percent of Float0.0%
Shares Short
(Prior Month)
22.0K
Short Ratio0.09 
Daily Volume34.0K
ADR Information
Shares/ADR2
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.